Currently, stem cells do not treat macular degeneration. Stem cell treatment of fundus lesions is still in the exploratory stage, and has not been used for clinical treatment, therefore, on the basis of uncertainty about the efficacy of the treatment, it is not possible to treat macular degeneration. In the case of dry macular degeneration, most of them are based on clinical observation and require regular review, and low vision correction can be performed in case of vision loss. In case of wet macular degeneration, when there is edema and neovascularization in the macular area, injection of anti-vascular endothelial growth factor drugs into the vitreous cavity can be considered for treatment, such as Compazine, Ranibizumab and so on. The drugs should be used according to the doctor’s prescription. It is recommended that patients with macular degeneration go to the hospital for timely examination and take targeted treatment according to different types and different signs.